close Video

NEW You can now listen to Fox News articles!

A drug intended to treat menopause symptoms could double as breast cancer prevention .

New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly reduced" breast tissue cell growth, which is a major indicator of cancer progression.

A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern.

PROSTATE CANCER DRUG NOW AVAILABLE TO MORE PATIENTS WITH AGGRESSIVE FORM OF DISEASE

This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer.

The women were sep

See Full Page